NCT02309515 2021-01-19Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell LymphocytosisMayo ClinicPhase 2 Terminated12 enrolled 8 charts